These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3841069)

  • 21. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Eur J Pharmacol; 1980 May; 63(2-3):145-57. PubMed ID: 6103814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of (+)- and (-)-oxaprotiline administered repeatedly on the dopamine system.
    Maj J; Klimek V; Rogóz Z; Skuza G; Sowińska H
    J Neural Transm Gen Sect; 1991; 86(1):11-23. PubMed ID: 1751026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?
    Ferretti C; Ghi P; Blengio M; Gaietta G; Barrera G; Genazzani E
    Eur J Pharmacol; 1989 Jul; 166(2):149-56. PubMed ID: 2551698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurochemical effects of prenatal haloperidol exposure.
    Scalzo FM; Holson RR; Gough BJ; Ali SF
    Pharmacol Biochem Behav; 1989 Dec; 34(4):721-5. PubMed ID: 2533691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
    Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z
    Eur J Pharmacol; 1998 Jun; 351(1):31-7. PubMed ID: 9698202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding.
    Daré E; Fetissov S; Hökfelt T; Hall H; Ogren SO; Ceccatelli S
    Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):500-8. PubMed ID: 12684742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system.
    Klimek V; Nielsen M
    Eur J Pharmacol; 1987 Jul; 139(2):163-9. PubMed ID: 3308491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of thyrotropin-releasing hormone on general behavior and striatal [3H]spiperone binding in developing rats.
    Oki K; Kinoshita Y; Nomura Y; Segawa T
    J Pharmacobiodyn; 1983 Sep; 6(9):607-12. PubMed ID: 6418875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reserpine-induced locomotor stimulation in mice chronically treated with typical and atypical antidepressants.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    Eur J Pharmacol; 1983 Mar; 87(4):469-74. PubMed ID: 6852100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that exposure to methyl mercury during gestation induces behavioral and neurochemical changes in offspring of rats.
    Cagiano R; De Salvia MA; Renna G; Tortella E; Braghiroli D; Parenti C; Zanoli P; Baraldi M; Annau Z; Cuomo V
    Neurotoxicol Teratol; 1990; 12(1):23-8. PubMed ID: 2156144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    J Neural Transm Gen Sect; 1989; 78(1):1-8. PubMed ID: 2569028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic uridine treatment reduces the level of [3H]spiperone-labelled dopamine receptors and enhances their turnover rate in striatum of young rats: relationship to dopamine-dependent behaviours.
    Farabegoli C; Merlo Pich E; Cimino M; Agnati LF; Fuxe K
    Acta Physiol Scand; 1988 Feb; 132(2):209-16. PubMed ID: 2906500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
    Boehme RE; Ciaranello RD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of assay conditions in determining agonist potency at D2 dopamine receptors in striatal homogenates.
    de Vries DJ; Beart PM
    Brain Res; 1986 Jul; 387(1):29-35. PubMed ID: 3742232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Behavioral and neurochemical changes in pups prenatally treated with methamphetamine].
    Fujiwara Y
    Yakubutsu Seishin Kodo; 1985 Sep; 5(3):251-9. PubMed ID: 3000110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M
    J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.